Showing 15 posts of 362 posts found.

coronavirus’s weekly COVID-19 news round-up

March 10, 2021
Research and Development COVID, COVID Vaccine, COVID-19, coronavirus, covid round-up

The past week has continued to see positive COVID-19 news; CytoDyn’s treatment for patients with severe symptoms of the virus …

GSK building

GSK’s Phase II otilimab study on COVID-19 patients promising for over-70s

February 26, 2021
Medical Communications COVID-19, GSK, coronavirus, covid-19 treatment, otilimab

GlaxoSmithKline’s (GSK) Phase II OSCAR study of their otilimab antibody’s effect on COVID-19 patients has shown promising results in older …

Pfizer COVID-19 vaccine proven 94% effective in biggest study yet

February 15, 2021
Sales and Marketing COVID-19, Pfizer, Pfizer vaccine, Vaccine, coronavirus

The Pfizer-BioNTech COVID-19 vaccine has been proven to be 94% effective, according to the first major study to evaluate the …


UAE rolls out Sinopharm COVID-19 vaccine amid conflicting reports of efficacy

December 15, 2020
Manufacturing and Production, Research and Development COVID-19, China, Sinopharm, UAE, coronavirus

The United Arab Emirates has begun rolling out Sinopharm’s COVID-19 vaccine in its capital Abu Dhabi, despite claims that numerous …


New coronavirus strain identified in the UK

December 15, 2020
Manufacturing and Production, Research and Development COVID-19, UK, coronavirus, vaccines

A new variant of coronavirus has been identified in the UK, and is growing faster in some parts of England, …


Pfizer/BioNTech vaccine side effects feel like a “severe hangover”

November 12, 2020
Business Services COVID, Vaccine, coronavirus

Clinical trial participants receiving the Pfizer/BioNTech coronavirus vaccine have said it created side effects that felt similar to a “severe …


Head of UK vaccine taskforce grilled over government investment into her private equity firm

November 11, 2020
Research and Development COVID, UK COVID, coronavirus

Kate Bingham, the Head of the British Government’s vaccine taskforce, is facing further questions over a conflict of interest as …


Hotels, gyms and restaurants carry highest COVID-19 spread risk, new study says

November 11, 2020
Research and Development COVID, coronavirus

Reopening hotels, gyms and restaurants carries the highest risk of spreading coronavirus, according to a new study. 


Sinovac COVID-19 trial suspended in Brazil due to severe adverse event

November 10, 2020
Manufacturing and Production Brazil, COVID, COVID Vaccine, coronavirus

Brazil’s health regulator Anvisa has suspended a clinical trial for China’s Sinovac coronavirus vaccine due to the occurrence of a …

top_10_image_2’s weekly COVID-19 news round-up

November 6, 2020
Medical Communications COVID, COVID-19, EC, FDA, coronavirus

The top ten news stories this week focus on regulatory approvals as the European Commission has approved GlaxoSmithKline’s Zeljula as …


US could have avoided over 130,000 COVID-19 deaths, according to a new study

October 27, 2020
Manufacturing and Production COVID, COVID-19, Trump, coronavirus

New studies suggest that the US could have avoided over 130,000 deaths if it responded earlier and in a coordinated …


WHO warns regulators to consider all available evidence before approving remdesivir for COVID-19

October 26, 2020
Sales and Marketing COVID, COVID-19, Gilead, coronavirus

The World Health Organization’s Chief Scientist Soumya Swaminathan has warned that experts and regulators assessing the use of Gilead’s remdesivir …

covid_cell_1_8’s weekly COVID-19 news round-up

October 21, 2020
Research and Development COVID-19, coronavirus

The coronavirus news this week focuses on COVID-19 treatments, with Gilead’s remdesivir being found to have no impact on mortality …


‘Long COVID’ could be taking four different forms

October 16, 2020
Medical Communications coronavirus, covid symptoms, long covid, symptoms

People experiencing chronic illnesses after COVID-19 infections could be suffering from one of four separate conditions, according to new research. …


Eli Lilly COVID-19 antibody therapy trial paused over safety concerns

October 14, 2020
Research and Development COVID, Eli Lilly, coronavirus

Eli Lilly has stopped enrolling volunteers in clinical trials of its antibody treatment for the novel coronavirus over safety concerns.  …

Latest content